(5α,6α)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochloride

Danger

EC Number

245-549-9

CAS Number

23277-43-2

Formula

C21H27NO4.ClH

Tonnage Band

intermediate

Hazard Classification

Harmonised EU classification under CLP Regulation.

H300: Fatal if swallowed [Danger Acute toxicity, oral]; H302: Harmful if swallowed [Warning Acute toxicity, oral]; H310: Fatal in contact with skin [Danger Acute toxicity, dermal]; H312: Harmful in contact with skin [Warning Acute toxicity, dermal]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H330: Fatal if inhaled [Danger Acute toxicity, inhalation]; H332: Harmful if inhaled [Warning Acute toxicity, inhalation]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]

Regulatory Status

SVHC (Candidate List)

Authorisation Required

Restricted

Is (5α,6α)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochloride banned in the EU?

No specific ban or restriction. Check current ECHA records for the latest status.

External Resources

ECHA Infocard PubChem

Related Substances

1,9-diiodononane 24613-65-8 Danger 1,3-propanesultone 1120-71-4 Danger 1,2,3,4-tetrahydroisoquinoline 91-21-4 Danger 1-(chloromethyl)-3-phenoxybenzene 53874-66-1 Danger 1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine citrate 17076-90-3 Danger 1-(bromomethyl)-2-(trifluoromethyl)benzene 395-44-8 Danger

Data sourced from the European Chemicals Agency (ECHA). Information is provided for reference only. Always consult official ECHA records and relevant Safety Data Sheets for regulatory compliance.